ProQR Therapeutics N.V. (PRQR)

CIK 1612940 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ProQR Therapeutics N.V..

Recent SEC filings

FiledFormAccession number
Sep 9, 20266-K0001104659-26-106138
Aug 13, 20266-K0001104659-26-095422
Aug 13, 20266-K0001104659-26-095425
Aug 3, 202640001104659-26-089780
Jul 29, 2026SCHEDULE 13D/A0001104659-26-088126
Jul 29, 2026SCHEDULE 13G0001716774-26-000021
Jul 24, 2026SCHEDULE 13G/A0000059478-26-000071
Jul 21, 202640001104659-26-085234
Jul 15, 2026EFFECT9999999995-26-002315
Jul 15, 2026424B50001104659-26-083906
Jul 15, 2026SCHEDULE 13G/A0001104659-26-083818
Jul 13, 202640001104659-26-082890
Jul 8, 202640001104659-26-081762
Jul 6, 2026F-30001104659-26-080750
Jun 30, 20264/A0001104659-26-079319
Jun 30, 202640001104659-26-079316
Jun 30, 2026SCHEDULE 13D/A0001104659-26-079415
Jun 26, 2026424B50001104659-26-077891
Jun 26, 20266-K0001104659-26-077892
Jun 25, 20266-K0001104659-26-077506
Jun 3, 2026SCHEDULE 13D/A0001104659-26-070195
Jun 3, 202640001104659-26-070090
Jun 2, 202630001104659-26-069449
Jun 2, 20266-K0001104659-26-069450
May 12, 20266-K0001104659-26-058980